ES2052762T3 - Estructuras peptidicas, inmunogenos que las contienen y sus aplicaciones al control de la fertilidad. - Google Patents

Estructuras peptidicas, inmunogenos que las contienen y sus aplicaciones al control de la fertilidad.

Info

Publication number
ES2052762T3
ES2052762T3 ES88402973T ES88402973T ES2052762T3 ES 2052762 T3 ES2052762 T3 ES 2052762T3 ES 88402973 T ES88402973 T ES 88402973T ES 88402973 T ES88402973 T ES 88402973T ES 2052762 T3 ES2052762 T3 ES 2052762T3
Authority
ES
Spain
Prior art keywords
immunogenes
contain
applications
fertility control
peptidic structures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88402973T
Other languages
English (en)
Inventor
Jean-Michel Bidart
Dominique Bellet
Claude Bohuon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lafon Pharma SA
Original Assignee
Lafon Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Pharma SA filed Critical Lafon Pharma SA
Application granted granted Critical
Publication of ES2052762T3 publication Critical patent/ES2052762T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA ESTRUCTURA PEPTIDICA QUE COMPRENDE AL MENOS A) LA SECUENCIA 106 - 116 DE UNA B - CG O DE UNA B - LH, B) UNA SECUENCIA DE AL MENOS 5 ACIDOS AMINADOS CON AL MENOS UN RESIDUO LISINA. ESTAS ESTRUCTURAS PUEDEN USARSE PARA LA PREPARACION DE VACUNAS DESTINADAS AL CONTROL DE LA FERTILIDAD.
ES88402973T 1987-11-26 1988-11-25 Estructuras peptidicas, inmunogenos que las contienen y sus aplicaciones al control de la fertilidad. Expired - Lifetime ES2052762T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8716420A FR2623715B1 (fr) 1987-11-26 1987-11-26 Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite

Publications (1)

Publication Number Publication Date
ES2052762T3 true ES2052762T3 (es) 1994-07-16

Family

ID=9357207

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88402973T Expired - Lifetime ES2052762T3 (es) 1987-11-26 1988-11-25 Estructuras peptidicas, inmunogenos que las contienen y sus aplicaciones al control de la fertilidad.

Country Status (22)

Country Link
US (1) US5496551A (es)
EP (1) EP0323769B1 (es)
JP (1) JP2509312B2 (es)
KR (1) KR890008171A (es)
CN (1) CN1034208A (es)
AP (1) AP71A (es)
AT (1) ATE102957T1 (es)
AU (1) AU617716B2 (es)
DE (1) DE3888509T2 (es)
DK (1) DK660888A (es)
EG (1) EG18596A (es)
ES (1) ES2052762T3 (es)
FR (1) FR2623715B1 (es)
IE (1) IE883545L (es)
IL (1) IL88381A (es)
MA (1) MA21448A1 (es)
NO (1) NO885231L (es)
NZ (1) NZ227073A (es)
OA (1) OA08971A (es)
PT (1) PT89053B (es)
TN (1) TNSN88129A1 (es)
ZA (1) ZA888733B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9001709A (nl) * 1990-07-27 1992-02-17 Stichting Centr Diergeneeskund Peptiden en farmaceutische preparaten met een glycoprotene hormoon agonistische of antagonistische werking.
FR2710845B1 (fr) * 1993-10-08 1996-03-29 Lafon Labor Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG.
JPH08507604A (ja) * 1993-03-11 1996-08-13 ラボラトル エル．ラフォン ｈＣＧまたはｈＣＧのフラグメントを分泌する癌に対する診断用キットおよびかような癌の免疫療法用手段
FR2702494B1 (fr) * 1993-03-11 1995-06-09 Lafon Labor Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer.
US5688506A (en) 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
NZ508874A (en) * 1998-07-23 2004-03-26 Lilly Co Eli FSH and FSH variant formulations, products and methods of treating infertility.
US7994278B1 (en) * 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201770A (en) * 1973-05-07 1980-05-06 The Ohio State University Antigenic modification of polypeptides
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
DK159276C (da) * 1980-03-31 1991-02-18 Takeda Chemical Industries Ltd Fremgangsmaade til isolering af specifikke antistoffer og enzym-immunbestemmelsesmetode med anvendelse af det isolerede antistof
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
EP0142387A1 (en) * 1983-08-26 1985-05-22 Anda Biologicals Process for the preparation of vaccines specific for LH and HCG and process for their detection
WO1986007383A1 (en) * 1985-06-04 1986-12-18 Biotechnology Research Partners, Ltd. Autoantigen vaccines
CA1239346A (en) * 1985-06-04 1988-07-19 Gursaran P. Talwar Birth control vaccine
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides

Also Published As

Publication number Publication date
NO885231L (no) 1989-05-29
AP71A (en) 1990-02-24
KR890008171A (ko) 1989-07-10
EP0323769B1 (fr) 1994-03-16
PT89053B (pt) 1993-04-30
EP0323769A1 (fr) 1989-07-12
US5496551A (en) 1996-03-05
TNSN88129A1 (fr) 1990-07-10
MA21448A1 (fr) 1989-07-01
DK660888A (da) 1989-05-27
JP2509312B2 (ja) 1996-06-19
JPH01301696A (ja) 1989-12-05
AU617716B2 (en) 1991-12-05
EG18596A (en) 1993-07-30
ATE102957T1 (de) 1994-04-15
CN1034208A (zh) 1989-07-26
FR2623715B1 (fr) 1990-12-21
ZA888733B (en) 1990-08-29
DE3888509T2 (de) 1994-10-06
PT89053A (pt) 1988-12-01
AP8800110A0 (en) 1989-01-31
DK660888D0 (da) 1988-11-25
NZ227073A (en) 1990-06-26
DE3888509D1 (de) 1994-04-21
IE883545L (en) 1989-05-26
NO885231D0 (no) 1988-11-24
FR2623715A1 (fr) 1989-06-02
AU2596888A (en) 1989-06-01
IL88381A0 (en) 1989-06-30
OA08971A (fr) 1990-11-30
IL88381A (en) 1993-03-15

Similar Documents

Publication Publication Date Title
ES2054842T3 (es) Analogo del factor viii, procedimiento de preparacion y composicion farmaceutica que lo contiene.
PT87333A (pt) Cement composition curable at. low temperatures
PT81839B (pt) Processo de preparacao de formulacoes com propulsores de aerosol a base de clorofluorocarbono contendo medicamento
BR8905851A (pt) Processo para a deteccao de uma infeccao por aids em seres humanos;composicao de proteina de involucro do virus de aids;e kit de teste utilizavel na administracao intradermica para deteccao de uma infeccao por aids
BR9105737A (pt) Processo para reduzir a contaminacao de um produto de amplificacao,conjunto para uso em um tipo de procedimento de amplificacao e processo para amplificar uma sequencia de amplificacao de uma sequencia-alvo
ES2143716T3 (es) Composicion de vacuna que contiene adyuvantes.
DK213784A (da) Ikke-toxinogene vibrio choleraemutanter
ATE141946T1 (de) Hiv-2-virusvarianten
DK234780A (da) 6beta,7beta,15,16-dimethylen-1,4-androstadien-3-oner fremgangsmaade til fremstilling heraf og anvendelsen heraf som laegemiddel
ES2052762T3 (es) Estructuras peptidicas, inmunogenos que las contienen y sus aplicaciones al control de la fertilidad.
IL82459A0 (en) Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems
ES2089732T3 (es) Procedimiento para elaborar acilisetionatos de sodio.
DK684188A (da) Forankringskonstruktion
AR009600A1 (es) Secuencia de acido nucleico y aminoacidos relacionados con helicobacter pylori y composiciones de vacuna de la misma.
ES2032582T3 (es) Procedimiento para preparar derivados de la oxima del 1,2,5,6,-tetrahidropiridin -3-carboxialdehido.
IT1230718B (it) Fluorurazione diretta di fluoro b sultoni ai corrispondenti fluorossi fluorosulfonil fluorocomposti.
ES2061603T3 (es) Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos.
MX9304026A (es) Dispositivo vibrador para maquinaria.
DK0469064T3 (da) Anvendelse af C-20- til C-26-alifatiske alkoholer til fremstilling af et lægemiddel til behandling af virusinfektioner
SE7904284L (sv) Farmaceutiska beredningar som innehaller prostaglandiner samt forfarande for framstellning av dem
ES2063897T5 (es) Vacuna contra el virus del colera porcino y diagnostico.
ES492195A0 (es) Clavo elastico para la reduccion de fractura de trocanter e implantacion que utiliza este clavo elastico
BR8004778A (pt) Processo para a preparacao de esteres de acidos n-metil-o-pirazol(4)il-carbamicos,composicoes praguicidas e sua aplicacao
DK199683D0 (da) Fremgangsmade til fremstilling af 3-vinylsubstituerede 2,2-dimethylcyclopropan-1-carboxylsyrer eller deres estere, ved fremgangsmaden anvendelige mellemprodukter samt disses fremstilling
BR8004335A (pt) Processo para a preparacao de esteres de acidos n,n-dimetil-o-pirimidinil-carbamicos e de hidroxipirimidinas,composicoes praguicidas e sua aplicacao

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 323769

Country of ref document: ES